Searched for
FAMOTIDINE
Buy J B Chemicals & Pharmaceuticals, target price Rs 2,225: JM FinancialJM Financial maintains a buy call on J B Chemicals & Pharmaceuticals, setting a target price of Rs 2,225. The brokerage believes a ban on r...- Marksans Pharma gets final USFDA nod for generic version of Famotidine tabletsMarksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Famotidine tablet...
- Stocks in the news: Keystone Realtors, IndiGo, BASF, Inox Leisure and Apollo TyresRustomjee Group's Keystone Realtors will make its Dalal Street debut on Thursday as the company issued shares in the range of Rs 514-541 ap...
- Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs re...
- Jhunjhunwala’s pharma bet dives after 'optically' good Q1; targets cutICICI Securities said Lupin’s performance was below expectations due to a dip in US sales and lower gross margin. It said US sales would re...
- Alkem Laboratories launches Ibuprofen, Famotidine tablets in US marketDrug firm Alkem Laboratories on Wednesday announced the launch of Ibuprofen and Famotidine tablets, used to relieve the symptoms of rheumat...
- Sun Pharma, Dr Reddy's, Aurobindo recall products in the US marketAs per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, whi...
- Trump doing well, undergoing Remdesivir therapy: White House doctorWhite House physician Sean Conley said medical specialists have recommended Remdesivir therapy to treat the president's COVID-19 infection.
- What we know, and what we don't, about Trump's coronavirus diagnosisThere are many unanswered questions surrounding President Donald Trump's COVID-19 diagnosis and treatment.
- US Medicare could have saved $1 billion by substituting branded drugs, says studyThe revelation is significant for India since Indian pharma companies supply 40 per cent of generic drugs consumed in the US.
- Dr Reddy's Lab recalls Famotidine tablets from US marketAs many as 5,69,376 bottles of Famotidine tablets, 10 mg belonging to multiple lots packaged in 30-count, are being recalled nationwide.
- Lupin's US arm recalls 12,888 bottles of ulcer drug in USThe reason for the recall is current Good Manufacturing Practise (CGMP) deviations, United States Food and Drug Administration (USFDA) said...
- Aurobindo Pharma gains as Credit Suisse initiates coverageShares of Aurobindo Pharma surged over 4 per cent in trade on Tuesday as analysts make a bee-line to add the stock to their portfolio.
- Twenty stocks in focus in Thursday morning tradeThe Indian market is expected to open higher on Thursday. Here is a list of top twenty stocks that are likely to be in focus today.
- Aurobindo Pharma gets US Food and Drug Administration nod for two drugsThe drug is bio-equivalent and therapeutically equivalent to the reference listed product Pepcid AC Tablets -- 10 mg and 20 mg of McNeil Co...
- Aurobindo Pharma gets USFDA nod for acid reflux treatment drugAurobindo Pharma has received final approval from the US health regulator to manufacture and market Famotidine Tablets used for acid reflux...
- Wockhardt recalls over 50 lakh bottles of various drugs in USAs per the information available on the USFDA, Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
- Wockhardt recalls over 1.62 lakh cartons of drugs in USs per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for...
- How to avoid stomach problemsStressful work, frequent tea & smoking breaks, bad eating habits all add up to that clawing pain in the stomach. But there's a solution, sa...
- DRL to rope in US cos for OTC drugsDr Reddy’s Laboratories is on course to scale up its private label drug business in the US, riding on the initial success of its tie-up wit...
Load More
